Racial, ethnic, and socioeconomic disparities in rates of stage IV prostate cancer after USPSTF category "D" recommendation against prostate-specific antigen screening: a retrospective cohort study

被引:0
|
作者
Thakker, Parth U. [1 ]
Perry, Alan G. [2 ]
Hemal, Ashok K. [1 ]
Bercu, Caleb H. [1 ,2 ]
Petrou, Steven P. [2 ]
Pak, Raymond W. [2 ]
Broderick, Gregory A. [2 ]
Thiel, David D. [2 ]
Dora, Chandler D. [2 ]
Lyon, Timothy D. [2 ]
Igel, Todd C. [2 ]
Craven, Timothy E. [2 ]
Pathak, Ram A. [2 ]
机构
[1] Atrium Wake Forest Baptist Hlth, Dept Urol, Winston Salem, NC USA
[2] Mayo Clin, Dept Urol, 4500 San Pablo Rd S, Jacksonville, FL 32224 USA
关键词
African American; blood screening; Hispanics; prostate cancer (PCa); urology1103; MEN;
D O I
10.21037/tau-24-90
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Background: In 2012 the United States Preventative Services Task Force (USPSTF) changed its prostate-specific antigen (PSA) screening recommendation to a category "D". The purpose of this study is to examine racial, ethnic, and socioeconomic differences in risk of presentation with metastatic prostate cancer (mPCa) at time of diagnosis before and after the 2012 USPSTF category "D" recommendation. Methods: This is a population-based cohort study. We identified patients with mPCa at diagnosis within the National Cancer Database from 2004-2017. Logistic regression models were used to examine associations of mPCa with age, race, ethnicity, geographic location, education level, income, and insurance status. Linear regression models assuming underlying binomial distribution were fitted to annual percentage of mPCa at diagnosis for years 2012-2017 to evaluate the post category "D" recommendation era. Results: From 2004 to 2017, 88,987 patients presented with mPCa. A higher percentage of mPCa was noted post-USPSTF category "D" recommendation, with a disproportionately greater increase observed among Hispanics and non-Hispanic Blacks [Delta slope/year: Hispanics (0.0092), non-Hispanic Blacks (0.0073) and non-Hispanic Whites (0.0070)]. Insurance status impacts race/ethnicity differently: uninsured Hispanics were 3.66 times more likely to present with mPCa than insured Hispanics, while uninsured non-Hispanic Blacks were 2.62 times more likely to present with mPCa than insured non-Hispanic Blacks. Household income appears to be associated with differences in mPCa, particularly among non-Hispanic Blacks. Those earning <$30,000 were more likely to present with mPCa compared to higher income brackets. Conclusions: Since the USPSTF grade "D" recommendation against PSA screening, the percentage of mPCa at diagnosis has increased, with a higher rate of increase among Hispanic and non-Hispanic Blacks compared to non-Hispanic Whites.
引用
收藏
页码:1092 / 1103
页数:12
相关论文
共 50 条
  • [41] Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study
    Kim, Jun Seop
    Chung, Jae Hoon
    Song, Wan
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Change
    Seo, Seong Il
    Lee, Hyun Moo
    Jeon, Seong Soo
    JOURNAL OF YEUNGNAM MEDICAL SCIENCE, 2023, 40 (04): : 412 - 418
  • [42] Cumulative risk of developing prostate cancer in men with low (2.0ng/mL) prostate-specific antigen levels: A population-based screening cohort study in Japan
    Sawada, Kiyoshi
    Kitagawa, Yasuhide
    Ito, Kazuto
    Takeda, Yasuo
    Mizokami, Atsushi
    Namiki, Mikio
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (06) : 560 - 565
  • [43] Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study
    Zeng, Hongmei
    Xu, Mengyuan
    Xie, Yingwei
    Nawrocki, Sergiusz
    Morze, Jakub
    Ran, Xianhui
    Shan, Tianhao
    Xia, Changfa
    Wang, Yixin
    Lu, Lingeng
    Yu, Xue Qin
    Azeredo, Catarina Machado
    Ji, John S.
    Yuan, Xiaomei
    Curi-Quinto, Katherine
    Liu, Yuexin
    Liu, Bingsheng
    Wang, Tao
    Ping, Hao
    Giovannucci, Edward L.
    ECLINICALMEDICINE, 2023, 62
  • [44] PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMY AND IMMEDIATE ADJUVANT HORMONAL TREATMENT FOR STAGE D1 PROSTATE-CANCER ARE PREDICTIVE OF EARLY DISEASE OUTCOME
    CHENG, WS
    BERGSTRALH, EJ
    FRYDENBERG, M
    ZINCKE, H
    EUROPEAN UROLOGY, 1994, 25 (03) : 189 - 193
  • [45] Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995
    Post, PN
    Kil, PJM
    Crommelin, MA
    Schapers, RFM
    Coebergh, JWW
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) : 705 - 709
  • [46] p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study
    Casale, Paolo
    Saita, Alberto
    Lazzeri, Massimo
    Lughezzani, Giovanni
    Hurle, Rodolfo
    Sulo, Vittorio Fa
    Mondellini, Giulio M.
    Paciotti, Marco
    Domanico, Luigi
    Lista, Giuliana
    Maffei, Davide
    Monari, Marta
    Motta, Lucia
    Bini, Vittorio
    Ceriotti, Ferruccio
    Guazzoni, Giorgio
    Buffi, Nicolo M.
    MINERVA UROLOGICA E NEFROLOGICA, 2019, 71 (03) : 273 - 279
  • [47] INCREASED INCIDENCE OF LYMPH NODE METASTASIS AFTER UNITED STATES PREVENTIVE SERVICES TASK FORCE GRADE D RECOMMENDATION FOR PROSTATE-SPECIFIC ANTIGEN SCREENING: LESS IS NOT MORE
    Stencel, Michael
    Patel, Apexa
    Hale, Nathan
    Deem, Samuel
    JOURNAL OF UROLOGY, 2021, 206 : E1005 - E1005
  • [48] Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study
    Gacci, Mauro
    Cai, Tommaso
    Siena, Giampaolo
    Minervini, Andrea
    Torshizi, Mozhgan Fayaz
    Bartolini, Matteo
    Gianni, Gianluca
    Saieva, Calogero
    Ceroti, Mauro
    Detti, Beatrice
    Livi, Lorenzo
    Pupi, Alberto
    Carini, Marco
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (03) : 259 - 267
  • [49] Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study
    Preeti Zanwar
    Yu-Li Lin
    Yong-Fang Kuo
    James S. Goodwin
    BMC Health Services Research, 16
  • [50] Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U. S. Medicare public insurance claims data: a retrospective cohort study
    Zanwar, Preeti
    Lin, Yu-Li
    Kuo, Yong-Fang
    Goodwin, James S.
    BMC HEALTH SERVICES RESEARCH, 2016, 16